Skip to main content
Article
Abstract 37: Anti-OX40 (MEDI6469) prior to definitive surgical resection in patients with head and neck squamous cell carcinoma
Clinical Cancer Research (2017)
  • R. Bryan Bell, Oregon Health & Science University
  • Rom S. Leidner, Columbia University
  • Rebekka A. Duhen
  • Carmen Ballesteros-Merino, Providence Portland Medical Center
  • Zipei Feng, Oregon Health & Science University
  • Yoshinobu Koguchi, Providence Portland Medical Center
  • Carlo B. Bifulco, University of Milan
  • Brendan D. Curti, Providence Portland Medical Center
  • Walter J. Urba
  • Bernard A. Fox, Oregon Health & Science University
  • Andrew D. Weinberg, University of California, San Diego
Disciplines
Publication Date
December 1, 2017
DOI
10.1158/1557-3265.AACRAHNS17-37
Citation Information
R. Bryan Bell, Rom S. Leidner, Rebekka A. Duhen, Carmen Ballesteros-Merino, et al.. "Abstract 37: Anti-OX40 (MEDI6469) prior to definitive surgical resection in patients with head and neck squamous cell carcinoma" Clinical Cancer Research Vol. 23 (2017) p. 37 - 37
Available at: http://works.bepress.com/walter-urba/21/